SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Crum Brian T

(Last)

(First)

(Middle)

8800 TECHNOLOGY FOREST PL

(Street)

THE WOODLANDS

77381

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/28/2019

3. Issuer Name and Ticker or Trading Symbol
LEXICON PHARMACEUTICALS, INC. [ LXRX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, General Counsel & Secr.

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	22,925	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽¹⁾	02/15/2020	Common Stock	2,857	$13.3	D
Stock Option (Right to Buy)	⁽²⁾	02/23/2021	Common Stock	10,000	$12.67	D
Stock Option (Right to Buy)	⁽³⁾	02/15/2022	Common Stock	10,571	$12.6	D
Stock Option (Right to Buy)	⁽⁴⁾	02/08/2023	Common Stock	8,747	$14.63	D
Stock Option (Right to Buy)	⁽⁵⁾	02/06/2024	Common Stock	13,499	$12.04	D
Stock Option (Right to Buy)	⁽⁶⁾	02/05/2025	Common Stock	19,391	$6.23	D
Stock Option (Right to Buy)	⁽⁷⁾	02/11/2026	Common Stock	23,470	$8.2	D
Restricted Stock Units	⁽⁸⁾	⁽⁸⁾	Common Stock	2,515	⁽⁹⁾	D
Stock Option (Right to Buy)	⁽¹⁰⁾	02/09/2027	Common Stock	14,160	$14.44	D
Restricted Stock Units	⁽¹¹⁾	⁽¹¹⁾	Common Stock	3,035	⁽⁹⁾	D
Stock Option (Right to Buy)	⁽¹²⁾	02/08/2028	Common Stock	23,040	$9.79	D
Restricted Stock Units	⁽¹³⁾	⁽¹³⁾	Common Stock	10,237	⁽⁹⁾	D
Stock Option (Right to Buy)	⁽¹⁴⁾	02/07/2029	Common Stock	49,950	$5.16	D
Restricted Stock Units	⁽¹⁵⁾	⁽¹⁵⁾	Common Stock	33,300	⁽⁹⁾	D
Stock Option (Right to Buy)	⁽¹⁶⁾	05/17/2020	Common Stock	7,142	$10.64	D

Explanation of Responses:

1. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/15/2011) and vests 1/48th per month for each month of service thereafter.

2. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/23/2012) and vests 1/48th per month for each month of service thereafter.

3. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/15/2013) and vests 1/48th per month for each month of service thereafter.

4. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/8/2014) and vests 1/48th per month for each month of service thereafter

5. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/6/15) and vests 1/48th per month for each month of service thereafter.

6. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/5/16) and vests 1/48th per month for each month of service thereafter.

7. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/11/2017) and vests 1/48th per month for each month of service thereafter.

8. Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

9. Each restricted stock unit represents a contingent right to receive one share of common stock.

10. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/9/2018) and vests 1/48th per month for each month of service thereafter

11. Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.

12. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/8/2019) and vests 1/48th per month for each month of service thereafter.

13. Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter.

14. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (2/7/2020) and vests 1/48th per month for each month of service thereafter

15. Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2020 and vest an additional one third on February 28 of each of the two succeeding years thereafter.

16. Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (5/17/2011) and vests 1/48th per month for each month of service thereafter.

	/s/ Brian T. Crum	11/04/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.